This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Millennium Pharmaceuticals Limited. Active years: 2014-2020.
Company Filing History:
Years Active: 2014-2020
Title: Liting Ma: Innovator in Cancer Treatment
Introduction
Liting Ma is a prominent inventor based in Needham, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cancer treatment. With a total of 2 patents, his work is recognized for its potential impact on medical therapies.
Latest Patents
Liting Ma's latest patents include innovative chemical entities that serve as inhibitors of ATG7. The first patent, titled "ATG7 inhibitors and the uses thereof," discloses chemical entities that can be useful in treating cancer. These compounds are described by a specific formula and include pharmaceutically acceptable salts. The second patent, "Substituted hydroxamic acids and uses thereof," provides additional compounds that further enhance the therapeutic options available for cancer treatment.
Career Highlights
Throughout his career, Liting Ma has been associated with Millennium Pharmaceuticals Limited, where he has played a crucial role in advancing pharmaceutical research. His expertise in developing novel compounds has positioned him as a key figure in the industry.
Collaborations
Liting Ma has collaborated with notable colleagues, including Dylan Bradley England and Alexandra E Gould. These partnerships have contributed to the successful development of his patented inventions.
Conclusion
Liting Ma's innovative work in cancer treatment through his patents demonstrates his commitment to advancing medical science. His contributions are expected to have a lasting impact on the field of pharmaceuticals.